Report title: ADELCO-COMPANY INSIGHT
from TF Market Research
13 page report published Nov 19, 2008

Price $480.00 available for immediate download Adobe Acrobat
This report is also available for purchase on a per-page basis.
Report Overview
 
Purchase by Section
 
Search Inside
...ADELCO is a manufacturer of dyes and allied chemical s. The company was established in #### with an aim to maintain a strict control of hygiene and quality factors in both the producti on process and services it offers. ADELCO's most important activity is the production of modern Pha rmaceutical Specialities and toiletry cosmetics. Its cosmetics are scientifically manufac tured and are suitable for all the family, offering the finest quality and excellent results. Its pharmaceutical products include: Antidepressants, Tranquilisers, Neuroleptic, Cardiovascular, Coronary Vasodilator, Antihypertensive, Tranquiliser - Anticholinergic, Antiinflamatory, Antihistamine, etc. ADLECO has also been involved in the manufacturing of products for various companies known in the industry of pharmaceut icals and cosmetics such as: Parke Davis, Le Petti, Pfrimmer, Daiichi, Cox, Revlon, Perlier, English Leather Cosmed, Isis and Ashvik. LSA. Life Science Analytics,...

Source: LIFE SCIENCE ANALYTICS
Author: HARINATHA, G.
Company: ADELCO
Geographic Regions: EUROPE, GREECE, SOUTHERN EUROPE
Non-Billable Page Numbers: 2

Sections
TitleStarting PageNumber of Pages
Company Information11
Adelco [NonUS -- Symbol : Private]11
Formation Date: 193411
Business Summary11
Product Glance31
Trial Phase31
No of Products31
Diseasehub Classification31
Disease Hub31
Product Summary41
Products41
Condition Treated42
Trial Phase Source Partner42
Product Details51
1. Depramine Disease Hub Description51
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 2. Minitran Disease Hub Description51
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 3. Notorium Disease Hub Description51
Therapeutic Indication Drug Class52
Current Trial Trial Details Last Updated 4. Saturnil Disease Hub Description61
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 5. Stedon Disease Hub Description61
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 6. Solidon Disease Hub Description61
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 7. Procardol Disease Hub Description61
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 8. Adezan Disease Hub Description61
Current Trial Trial Details Last Updated 9. Mesonex Disease Hub Description71
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 10. Neourizine Disease Hub Description71
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 11. Normolose Disease Hub Description71
Therapeutic Indication Drug Class Current Trial M Trial Details Last Updated 12. Normolose-H Disease Hub Description71
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 13. Distedon Disease Hub Description71
Therapeutic Indication Current Trial Trial Details Last Updated 14. Butazinal Disease Hub Description81
Therapeutic Indication Current Trial Trial Details Last Updated 15. Istamex Disease Hub Description81
Therapeutic Allergy Indication Drug Class Current Trial M Trial Details Last Updated 16. Bronchotussine Disease Hub81
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 17. Vicholex Disease Hub Description81
Therapeutic Indication Current Trial Trial Details Last Updated 18. Adelcort81
Disease Hub Description91
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 19. Dermol Disease Hub Description91
Therapeutic Indication Current Trial Trial Details Last Updated 20. Dermolate Disease Hub Description91
Therapeutic Skin Indication Drug Class Topical Current Trial M Trial Details Presently Last Updated 9/25/2008 21.91
Therapeutic Skin Indication Drug Class Current Trial M Trial Details Last Updated 22. Anaboline Depot Disease Hub91
Therapeutic92
Indication Drug Class Current Trial Trial Details Last Updated 23. Neolut Disease Hub Description101
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 24. Panto B+C Disease Hub Description101
Therapeutic Indication Current Trial Trial Details Last Updated 25. C- Rutine Disease Hub Description101
Therapeutic Indication Current Trial Trial Details Last Updated 26. Filicine Disease Hub Description101
Therapeutic Indication Current Trial Trial Details Last Updated 27. Paroticin Disease Hub Description101
Indication Current Trial Trial Details Last Updated 28. Oradin Disease Hub Description111
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 30. Adelcopen Disease Hub Description111
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 31. Acinic Disease Hub Description111
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated 32. Ponotex Disease Hub Description111
Therapeutic Indication Current Trial Trial Details Last Updated 33. Salopyrine Disease Hub Description121
Therapeutic Indication Drug Class Current Trial Trial Details Last Updated122

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
 TF Market Research
TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.
Price: $480.00